RETRACTION: Clinical Importance of Somatostatin Receptor 2 (SSTR2) and Somatostatin Receptor 5 (SSTR5) Expression in Thyrotropin-Producing Pituitary Adenoma (TSHoma) (Retraction of Vol 23, Pg 1947, 2017)

被引：1
|
作者：
Song, Hao
Chi, Yuchun
Shi, Chunling
Xu, Miao
Yu, Benxia
Zhang, Zhongsheng
机构：
来源：
MEDICAL SCIENCE MONITOR | 2018年 / 24卷
关键词：
D O I：
10.12659/MSM.912715
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：5904 / 5904
页数：1
相关论文
共 38 条
  • [1] RETRACTED: Clinical Importance of Somatostatin Receptor 2 (SSTR2) and Somatostatin Receptor 5 (SSTR5) Expression in Thyrotropin-Producing Pituitary Adenoma (TSHoma) (Retracted Article)
    Yu, Benxia
    Zhang, Zhongsheng
    Song, Hao
    Chi, Yuchun
    Shi, Chunling
    Xu, Miao
    MEDICAL SCIENCE MONITOR, 2017, 23 : 1947 - 1955
  • [2] Somatostatin receptor SSTR2A and SSTR5 expression in neuroendocrine breast cancer
    Terlevic, Robert
    Balja, Melita Peric
    Tomas, Davor
    Skenderi, Faruk
    Kruslin, Bozo
    Vranic, Semir
    Demirovic, Alma
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2019, 38 : 62 - 66
  • [3] Does the response of GH-secreting pituitary adenomas to octreotide depend on the cellular localization of the somatostatin receptor subtypes SSTR2 and SSTR5?
    Pisarek, Hanna
    Pawlikowski, Marek
    Kunert-Radek, Jolanta
    Winczyk, Katarzyna
    ENDOKRYNOLOGIA POLSKA, 2010, 61 (02) : 178 - 181
  • [4] Immunohistochemical expression of somatostatin receptors SSTR2A and SSTR5 in 299 pituitary adenomas
    Fuchs, Talia L.
    Sioson, Loretta
    Sheen, Amy
    Clarkson, Adele
    Gill, Anthony J.
    PATHOLOGY, 2018, 50 (04) : 472 - 474
  • [5] Detection of Somatostatin Receptors, SSTR2A and SSTR5, in TSH Producing Pituitary Adenomas: Patho-Clinical Correlation
    Takei, M.
    Kajiya, H.
    Inomoto, C.
    Takekoshi, S.
    Teramoto, A.
    Osamura, R. Y.
    LABORATORY INVESTIGATION, 2009, 89 : 120A - 120A
  • [6] Detection of Somatostatin Receptors, SSTR2A and SSTR5, in TSH Producing Pituitary Adenomas: Patho-Clinical Correlation
    Takei, M.
    Kajiya, H.
    Inomoto, C.
    Takekoshi, S.
    Teramoto, A.
    Osamura, R. Y.
    MODERN PATHOLOGY, 2009, 22 : 120A - 120A
  • [7] Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms
    Buscail, L.
    Esteve, J.-P.
    Saint-Laurent, N.
    Bertrand, V.
    Proceedings of the National Academy of Sciences of the United States of America, 1995, 92 (05):
  • [8] Somatostatin Receptor 2 (SSTR2) Expression, as well as Combined Somatostatin and SSTR2 Expression, is Associated with Better Clinical Outcome and Prognosis in Rectal Neuroendocrine Tumors
    Kim, Joo Young
    Hong, Seung-Mo
    Kim, Jisup
    LABORATORY INVESTIGATION, 2024, 104 (03) : S738 - S738
  • [9] INHIBITION OF CELL-PROLIFERATION BY THE SOMATOSTATIN ANALOG RC-160 IS MEDIATED BY SOMATOSTATIN RECEPTOR SUBTYPES SSTR2 AND SSTR5 THROUGH DIFFERENT MECHANISMS
    BUSCAIL, L
    ESTEVE, JP
    SAINTLAURENT, N
    BERTRAND, V
    REISINE, T
    OCARROLL, AM
    BELL, GI
    SCHALLY, AV
    VAYSSE, N
    SUSINI, C
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (05) : 1580 - 1584
  • [10] Prevalence and Clinical Correlations of Somatostatin Receptor-2 (SSTR2) Expression in Neuroblastoma
    Alexander, Natasha
    Marrano, Paula
    Thorner, Paul
    Naranjo, Arlene
    Van Ryn, Collin
    Martinez, Daniel
    Batra, Vandana
    Zhang, Libo
    Irwin, Meredith S.
    Baruchel, Sylvain
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2019, 41 (03) : 222 - 227
1234